Micro Labs USA and Saptalis Pharmaceuticals have formed a strategic collaboration to launch single-source and multisource generics in the United States.
Although polices have been introduced to increase the use of generics and biosimilars, large differences remain in the price and uptake of these medicines between countries.
Vilazodone hydrochloride tablets and empagliflozin tablets had a market value of $469 million and roughly $3.4 billion respectively, for the 12 months ended September 2019.